A senior US official said on Friday that the Biden administration is preparing for the possible need for Covid-19 booster vaccines.
Andy Slavit, a senior adviser to President Joe Biden’s Covid response team, told reporters at a press conference on Friday that extra footage in the future is definitely a potential event.
I would like to emphasize that there are certainly speculations on this subject, but it is far from saying what will happen.
If Americans need booster vaccines, the U.S. government may need to provide drug manufacturers with additional doses and plan to distribute the vaccines.
Slavit said on Friday that the administration is considering the need to keep the extra dose safe.
I assure you that as we make our plans, when the President orders the purchase of additional vaccines as we wish and we focus on all the opportunities to expand production here, we have a lot to think about.
Pfizer CEO Albert Baurla said in a comment published for the first time on Thursday that people will need a third dose or booster shot of Covid-19 within 12 months of being fully vaccinated.
He added that people may need to be vaccinated against annual coronaviruses such as seasonal flu.
Perhaps a situation would likely require a third dose in six to 12 months, followed by a yearly repeat from there, but all need to be confirmed.
During an event with CNBS Health, he again told CNBC’s Bertha Combs that forms will play a key role.
Suppression of the pool of people who may favor virus infection support
Pfizer and Modarna said the two-dose Covid-19 vaccine, using the same technology, was highly effective six months after the second dose.
However, although healthcare professionals expect the protection to wear off after a while, researchers still do not know how long the protection against the virus took six months after full vaccination.
On Thursday, David Kasler, chief science officer of Beadon’s administration’s Covid response, said Americans should expect to receive booster shots to guard against the coronavirus variant.
He told US lawmakers that the currently approved vaccines are highly protective, but important new forms could challenge the effectiveness of the vaccines.
We don’t know everything about the coronavirus crisis right now to the House Select subcommittee.
We’re studying the stability of the antibody response, he said. It may seem powerful, but it is somewhat declining and their form is undoubtedly compelling … they make these vaccines work even harder.
So I think we should wait for our encouragement for planning purposes, just for planning purposes.
Moderna CEO Stephen Bansell told CNBC on Wednesday that the company hopes to receive a booster vaccine for two doses of vaccine in the fall.